A core mission of C-STAR is to connect researchers with the right tools to develop and accurately assess technologies in the field of rehabilitation medicine. When first establishing their research protocol, investigators may face difficulty in navigating translational opportunities — from broader dissemination goals to licensing a technology to a manufacturer.
In a new webinar available to the C-STAR community, Dr. Levi Hargrove, PhD, Scientific Chair of the Regenstein Foundation Center for Bionic Medicine and an engineering core director for C-STAR, provides an inside look into the intricate process of translational research. The webinar, C-Star: Developing Advanced Prototypes for Clinical Testing and Commercial Translation, is available for free by registering through the Shirley Ryan AbilityLab Academy website.
Drawing upon his vast experience leading the Center for Bionic Medicine, a multidisciplinary research group within the Shirley Ryan AbilityLab that has successfully translated innovations for more than a decade, he provides examples of successful scientific translation. Some topics Dr. Hargrove discusses include:
- Obtaining funding for early-stage projects
- Navigating regulatory hurdles
- Establishing design and software reviews
- Developing a business plan
- Understanding the challenges of commercial translation in the context of rehabilitation research
- Taking a clinical concept from bench to bedside
- Realizing how the engineering core of C-STAR can support grantees and other stakeholder